bulgecin A: structure in first source; do not confuse with bulgecin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 444940 |
| CHEMBL ID | 1231509 |
| MeSH ID | M0358992 |
| Synonym |
|---|
| CHEMBL1231509 |
| 4-o-(4-o-sulfonyl-n-acetylglucosamininyl)-5-methylhydroxy-l-proline-taurine |
| BLG , |
| bulgecin a |
| BUL , |
| 2-{[(4s,5r)-4-{[2-(acetylamino)-2-deoxy-4-o-sulfo-beta-d-glucopyranosyl]oxy}-5-(hydroxymethyl)-l-prolyl]amino}ethanesulfonic acid |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1128919 | Competitive inhibition of Bacillus cereus 569/H metallo-beta-lactamase BcII by Eadie-Hofstee plot analysis | 2014 | European journal of medicinal chemistry, Apr-09, Volume: 76 | The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-β-lactamases and arginases. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||